Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.

Biotechnology

Nucleix

Chris Hibberd

Danny Frumkin

Mathias Ehrich

Michael G. Vicari

Michael D.

Eli Frydman

Radha Duttagupta

Adam Wasserstrom

Eran Bram

Aharona Shuali

Todd Myers

Research and Development

Advisory Team

Leadership Team

Software and IT Team

Product Development and Operations

Directorship Team